AIM: The present study explored (a) the discharge of breast cancer patients to primary care by specialists, at the end of hospital follow-up and (b) the experiences and views of general practitioners (GPs) regarding transfer of follow-up to the primary care setting. METHODS: A cross-sectional survey was performed by sending a self-administered questionnaire to 960 GPs working in the three northern provinces of the Netherlands. Data were analysed using descriptive statistics. RESULTS: Of 949 eligible questionnaires, 502 were returned, providing an adjusted response rate of 53%. In the year before the survey took place, one or more patients aged >60 years, and 5 years after breast-conserving therapy, were discharged to 22% of GPs (n=112) for follow-up. According to 56% of these GPs, transfer of follow-up was communicated by the hospital. The initiative to arrange follow-up visits and mammography appointments was mainly taken by patients. In this survey, 40% of GPs (n=200) were willing to accept exclusive responsibility for follow-up earlier than 5 years after completion of active treatment. Perceived barriers in current and future primary care-based follow-up included: communication with breast cancer specialists, patients' preference for specialist follow-up, GPs' oncology knowledge and skills and the organisation of follow-up in general practice. CONCLUSIONS: Primary care-based follow-up might be improved if breast cancer specialists discharge patients more actively to their GPs. Survivorship care plans are needed to facilitate communication across the primary/secondary interface and with patients. Training of GPs and developing administrative tools may be helpful in arranging follow-up care and using guidelines in general practice.
AIM: The present study explored (a) the discharge of breast cancerpatients to primary care by specialists, at the end of hospital follow-up and (b) the experiences and views of general practitioners (GPs) regarding transfer of follow-up to the primary care setting. METHODS: A cross-sectional survey was performed by sending a self-administered questionnaire to 960 GPs working in the three northern provinces of the Netherlands. Data were analysed using descriptive statistics. RESULTS: Of 949 eligible questionnaires, 502 were returned, providing an adjusted response rate of 53%. In the year before the survey took place, one or more patients aged >60 years, and 5 years after breast-conserving therapy, were discharged to 22% of GPs (n=112) for follow-up. According to 56% of these GPs, transfer of follow-up was communicated by the hospital. The initiative to arrange follow-up visits and mammography appointments was mainly taken by patients. In this survey, 40% of GPs (n=200) were willing to accept exclusive responsibility for follow-up earlier than 5 years after completion of active treatment. Perceived barriers in current and future primary care-based follow-up included: communication with breast cancer specialists, patients' preference for specialist follow-up, GPs' oncology knowledge and skills and the organisation of follow-up in general practice. CONCLUSIONS: Primary care-based follow-up might be improved if breast cancer specialists discharge patients more actively to their GPs. Survivorship care plans are needed to facilitate communication across the primary/secondary interface and with patients. Training of GPs and developing administrative tools may be helpful in arranging follow-up care and using guidelines in general practice.
Authors: Ryan P Merkow; Deborah Korenstein; Rubaya Yeahia; Peter B Bach; Shrujal S Baxi Journal: JAMA Intern Med Date: 2017-05-01 Impact factor: 21.873
Authors: Nicole P M Ezendam; Kim A H Nicolaije; Roy F P M Kruitwagen; Johanna M A Pijnenborg; M Caroline Vos; Dorry Boll; Marjo van Bommel; Lonneke V van de Poll-Franse Journal: J Cancer Surviv Date: 2014-05-28 Impact factor: 4.442
Authors: Lesly A Dossett; Janella N Hudson; Arden M Morris; M Catherine Lee; Richard G Roetzheim; Michael D Fetters; Gwendolyn P Quinn Journal: CA Cancer J Clin Date: 2016-10-11 Impact factor: 508.702
Authors: Archana Radhakrishnan; Yun Li; Allison K C Furgal; Ann S Hamilton; Kevin C Ward; Reshma Jagsi; Steven J Katz; Sarah T Hawley; Lauren P Wallner Journal: J Oncol Pract Date: 2019-03-11 Impact factor: 3.714